Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jan 14;3(1):2.
doi: 10.1186/1758-5996-3-2.

Understanding diabetes in patients with HIV/AIDS

Affiliations

Understanding diabetes in patients with HIV/AIDS

Sanjay Kalra et al. Diabetol Metab Syndr. .

Abstract

This paper reviews the incidence, pathogenetic mechanisms and management strategies of diabetes mellitus in patients with human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS). It classifies patients based on the aetiopathogenetic mechanisms, and proposes rational methods of management of the condition, based on aetiopathogenesis and concomitant pharmacotherapy.

PubMed Disclaimer

References

    1. HIV Data. http://www.unaids.org/en/KnowledgeCentre/HIVData/default.asp Accessed 22 December, 2010.
    1. Young F, Critchley JA, Johnstone LK, Unwin LC. A review of co-morbidity between infectious and chronic disease in Sub Saharan Africa: TB and Diabetes Mellitus, HIV and Metabolic Syndrome, and the impact of globalization. Globalization and Health. 2009;5:9. doi: 10.1186/1744-8603-5-9. - DOI - PMC - PubMed
    1. Samaras K, Wand H, Law M, Emery S, Cooper D, Carr A. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Federation and Adult treatment Panel III criteria. Diabetes Care. 2007;30(1):113–115. doi: 10.2337/dc06-1075. - DOI - PubMed
    1. De Wit S, Sabin CA, Weber R, Worm SW, Reiss P, Cazanave C, El-Sadr W, Monforte Ad'A, Fontas E, Law MG, Friss-Moller N, Phillips A. Incidence and Risk Factors for New-Onset Diabetes in HIV-Infected Patients. The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study Diabetes Care. 2008;31(6):1224–9. doi: 10.2337/dc07-2013. - DOI - PMC - PubMed
    1. Fichtenbaum CJ, Hadigan CM, Kotler DP, Treating morphologic and metabolic complications in HIV-infected patients on antiretroviral therapy. IAPAC Monthly. 2005. pp. 38–46. - PubMed

LinkOut - more resources